# 2026年1月6日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 从机制到表型：篮式试验的适用范围

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41489607)
**期刊：** Epilepsia
**PMID：** 41489607
**DOI：** 10.1002/epi.70086

### 第一部分 原文与翻译

**英文原标题：** From mechanism to phenotype: What fits in a basket trial.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 无可用摘要。

### 第二部分 AI 大师评价

本文似乎探讨了从疾病机制到临床表型在篮式试验设计中的关联与适用性。篮式试验是一种以分子机制或生物标志物为核心的创新临床试验设计，适用于多种疾病或亚型的验证。该题目暗示作者可能分析了不同机制与表型如何影响篮式试验的可行性和解释力。虽然缺乏摘要限制了对具体方法和数据的了解，但该研究预计在精准医学和试验设计优化方面具有启发意义。

---

## 2. 一种导致人类发育中大脑偏侧巨脑症及局灶性结节异位的新的 PTEN 变异。

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41489603)
**期刊：** Epilepsia
**PMID：** 41489603
**DOI：** 10.1002/epi.70088

### 第一部分 原文与翻译

**英文原标题：** A novel PTEN variant causing hemimegalencephaly and focal nodular heterotopias in the developing human brain.

> **英文摘要：**
> Brain development and subsequent brain function are highly sensitive to genetic mutations, which can result in severe neurodevelopmental malformations. Alterations in PTEN signaling cause a spectrum of developmental malformations and neurological diseases including epilepsy. To date, a detailed understanding of the neuropathological underpinnings of PTEN-associated brain malformations, particularly in fetuses, is missing. We have thus investigated a fetal case of hemimegalencephaly (HME), which is a rare disorder characterized by hemispheric overgrowth, developmental delay, and epileptic seizures. Our assessment of the male fetus includes genetic, radiologic, and histologic features and provides a comprehensive characterization of the cellular alterations in HME together with a genotypic correlation. Genetic analyses uncovered that hemispheric overgrowth was caused by a somatic second hit resulting in biallelic PTEN alteration in the affected brain tissue, although the unaffected hemisphere carried the same PTEN variant as the heterozygous germline variant. Based on the latter, we interpret that the PTEN mutation is not a dominant-negative variant. Within the outer subventricular zone of the enlarged cortex, we found small nodular heterotopias, which can be origins of focal epileptic seizures. Cell type-specific marker stainings revealed that the heterotopias consisted exclusively of SATB2 glutamatergic projection neurons. Altogether, our analyses and findings contribute to a deeper understanding of the pathomechanisms of a novel PTEN variant driving a severe brain malformation.

> **中文摘要：**
> 大脑的发育及其后续功能对基因突变极为敏感，这些突变可能导致严重的神经发育畸形。PTEN 信号通路的改变可引起多种发育畸形和神经系统疾病，包括癫痫。迄今为止，对于与 PTEN 相关的大脑畸形的神经病理学基础，尤其是在胎儿中的详细理解仍然缺乏。因此，我们研究了一个患有偏侧巨脑症（HME）的胎儿病例，这是一种以大脑半球过度生长、发育迟缓和癫痫发作为特征的罕见疾病。我们对该男性胎儿的基因学、影像学和组织学特征进行了评估，并提供了 HME 中细胞变化的全面特征描述及其与基因型的关联。遗传学分析发现，大脑半球的过度生长是由体细胞的第二次打击导致受累脑组织中 PTEN 的双等位基因改变引起的，而未受累的大脑半球携带相同的杂合生殖系 PTEN 变异。据此，我们推断该 PTEN 突变并非显性负效型变异。在增大的皮层外侧室管膜下区内，我们发现了小的结节状异位区，这些区域可能是局灶性癫痫发作的起源。细胞类型特异性标记染色显示，这些异位区完全由 SATB2 谷氨酸能投射神经元组成。总体而言，我们的分析和发现有助于更深入地理解一种新的 PTEN 变异所驱动的严重脑发育畸形的发病机制。

### 第二部分 AI 大师评价

本研究通过综合遗传学、影像学与组织学分析，报道了一个携带新型 PTEN 变异的胎儿偏侧巨脑症病例，并揭示该变异通过体细胞“第二次打击”机制导致双等位基因损伤。研究首次在胎儿时期详细描述了 PTEN 相关脑畸形的病理特征，并确定了由 SATB2 阳性谷氨酸能神经元构成的结节异位。其创新性在于将基因型与细胞层级的组织学异常联系起来，为理解 PTEN 相关神经发育障碍的机制提供了重要线索。局限性在于样本为单病例，仍需更多研究验证其普遍性。

---

## 3. 通过靶向Hsp90的药物cemdomespib可减少癫痫发作负荷并改变癫痫前临床模型的疾病进程

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41489467)
**期刊：** Epilepsia
**PMID：** 41489467
**DOI：** 10.1002/epi.70074

### 第一部分 原文与翻译

**英文原标题：** Targeting Hsp90 with cemdomespib reduces seizure burden and alters disease course in preclinical epilepsy models.

> **英文摘要：**
> OBJECTIVE: Epilepsy is a chronic neurological disorder characterized by recurrent seizures and frequent cognitive and psychiatric comorbidities. Although current antiseizure medications provide symptomatic relief, they fail to prevent or modify epileptogenesis. Heat shock protein 90 (Hsp90) is increasingly recognized as a regulator of neuroinflammatory and oxidative stress pathways implicated in seizure generation and disease progression. Here, we investigated the therapeutic potential of cemdomespib, a novel and selective Hsp90 inhibitor, across complementary preclinical models of epilepsy.
> 
> METHODS: In vitro, cemdomespib was evaluated in the low-magnesium model of epileptiform activity for its effects on neuronal calcium dynamics, mitochondrial membrane stability, and reactive oxygen species (ROS) generation. In vivo, acute seizure protection was assessed in the pentylenetetrazol (PTZ) model, and antiepileptogenic efficacy was tested in the kainic acid-induced status epilepticus (KA-SE) model using chronic video-electrocorticographic recordings. Behavioral outcomes relevant to epilepsy-associated comorbidities, including anxiety-like behavior and exploratory activity, were also examined.
> 
> RESULTS: Cemdomespib reduced epileptiform calcium oscillations, stabilized mitochondrial membrane potential, and suppressed ROS generation in vitro. In the PTZ model, 45% of pretreated animals were protected from seizures, and those that seized exhibited reduced severity, shorter duration, and delayed onset. In the KA-SE model, cemdomespib significantly mitigated the severity of SE and reduced the emergence of spontaneous recurrent seizures during the chronic phase, as evidenced by lower seizure frequency, decreased cumulative seizure burden, and prolonged latency to seizure onset. Furthermore, treated animals demonstrated improved anxiety-like behavior and enhanced exploratory activity.
> 
> SIGNIFICANCE: Cemdomespib confers both acute seizure protection and long-term suppression of epileptogenesis, likely through Hsp90-dependent regulation of mitochondrial integrity and redox signaling. These findings highlight Hsp90 inhibition as a promising therapeutic strategy for seizure control while also mitigating the progression of epileptogenesis and its associated neurobehavioral impairments.

> **中文摘要：**
> 研究目的：癫痫是一种以反复发作为特征的慢性神经系统疾病，常伴随认知和精神方面的共病。尽管现有的抗癫痫药物能够提供症状性缓解，但仍无法阻止或修饰癫痫的发生过程。热休克蛋白90（Hsp90）日益被认为是神经炎症及氧化应激通路的调节因子，这些通路与癫痫发作的发生和疾病进展密切相关。本研究旨在评估一种新型且选择性的Hsp90抑制剂cemdomespib在多种互补的癫痫前临床模型中的治疗潜力。
> 
> 研究方法：在体外实验中，采用低镁模型评估cemdomespib对神经元钙动态、线粒体膜稳定性及活性氧（ROS）生成的影响。在体内实验中，使用戊四氮（PTZ）模型评估急性抗发作保护作用，并在卡因酸诱导的持续癫痫（KA-SE）模型中，通过慢性视频脑皮层电图记录，检测其抗癫痫形成效应。同时，还评估与癫痫相关共病的行为学表现，包括类焦虑行为和探索活动。
> 
> 研究结果：在体外实验中，cemdomespib可减少类癫痫样钙振荡，稳定线粒体膜电位，并抑制ROS生成。在PTZ模型中，45%的预处理动物未出现发作，而其余发作的动物表现出发作严重程度降低、持续时间缩短及发作延迟。在KA-SE模型中，cemdomespib显著减轻了持续性癫痫的严重程度，并在慢性期降低了自发性复发发作的出现，包括较低的发作频率、减少的累积发作负荷及延长的首次发作潜伏期。此外，接受治疗的动物还表现出焦虑样行为改善和探索活动增强。
> 
> 研究意义：cemdomespib不仅提供急性抗发作保护，还能长期抑制癫痫形成，其作用机制可能通过Hsp90依赖的线粒体完整性与氧化还原信号通路调节实现。这一发现提示Hsp90抑制可能成为同时控制发作与阻缓癫痫病程进展及相关神经行为障碍的有前景的治疗策略。

### 第二部分 AI 大师评价

本研究探索了选择性Hsp90抑制剂cemdomespib在癫痫前临床模型中的作用，显示其能减轻急性发作并延缓癫痫形成。研究同时结合了体外细胞模型与多种体内动物模型，证明其通过维持线粒体稳定与抑制氧化应激发挥保护作用。这一结果为Hsp90作为癫痫治疗靶点提供了强有力的实验证据，具有潜在的转化意义。其局限在于仍属动物实验阶段，临床可行性和安全性尚待验证。

---

## 4. 在具有 GRIN 功能增强型变异个体中使用美金刚治疗与行为、发育及癫痫发作频率的改善相关

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41489401)
**期刊：** Epilepsia
**PMID：** 41489401
**DOI：** 10.1002/epi.70090

### 第一部分 原文与翻译

**英文原标题：** Memantine treatment in individuals with GRIN gain-of-function variants is associated with improvements in behavior, development, and seizure frequency.

> **英文摘要：**
> OBJECTIVE: GRIN-related disorders due to pathogenic variants in GRIN1, GRIN2A, GRIN2B, or GRIN2D genes are associated with altered N-methyl-D-aspartate receptor (NMDAR) function. Functional changes include gain (GoF) and loss of receptor function (LoF). Clinical reports describing the use of the NMDAR blocker memantine in GRIN-related disorders show a diverse and inconsistent spectrum of treatment responses.
> 
> METHODS: To evaluate clinical responses to memantine, we collected retrospective data on 34 individuals with GRIN variants, including 20 unpublished and 14 published cases. Variants were reclassified following American College of Medical Genetics and Genomics guidelines, and six in vitro functional assays were used to assess receptor function. We compared individuals with pathogenic GoF versus LoF in terms of associated clinical improvements, memantine sensitivity, and variant localization within the gene.
> 
> RESULTS: In 19 of the 34 variants, a pathogenic likely or possible GoF of the receptor was detected. Fourteen of 19 individuals (74%) benefited from memantine, comprising improvements in behavior (71%), development (50%), and seizure frequency (39%). Individuals with either LoF or a functionally indeterminate or no effect GRIN variant (15/34 individuals) showed significantly less benefit from memantine treatment but nevertheless rare adverse events (3/15). An increased distance of the variant from the memantine binding site was associated with a clinical benefit.
> 
> SIGNIFICANCE: Our retrospective observational study outlines the importance of correct classification of GRIN variants with regard to pathogenicity and functional consequence prior to applying memantine or other precision medicine approaches in clinical trials. Furthermore, the distance from a GoF variant to the memantine binding site correlated with a positive treatment response and may, at least in part, explain different degrees of therapeutic benefit.

> **中文摘要：**
> 研究目的：由于 GRIN1、GRIN2A、GRIN2B 或 GRIN2D 基因中的致病性变异导致的 GRIN 相关疾病与 N-甲基-D-天冬氨酸受体（NMDAR）功能改变有关。功能性变化包括受体功能的增强（GoF）或丧失（LoF）。关于在 GRIN 相关疾病中使用 NMDAR 阻断剂美金刚的临床报告显示，其治疗反应的谱系多样且不一致。
> 
> 研究方法：为评估美金刚的临床反应，我们收集了 34 名具有 GRIN 变异个体的回顾性数据，其中包括 20 例未发表和 14 例已发表的病例。依据美国医学遗传学与基因组学学会（ACMG）的指南重新分类这些变异，并采用六种体外功能测定评估受体功能。我们对具有致病性 GoF 与 LoF 变异的个体在临床改善、美金刚敏感性及变异在基因内的位置等方面进行了比较。
> 
> 研究结果：在 34 个变异中，有 19 个检测到受体功能的明确或可能增益性致病效应。在这些个体中，14/19（74%）从美金刚治疗中获益，包括行为改善（71%）、发育改善（50%）及癫痫发作频率减少（39%）。而携带 LoF 或功能未定型/无效应的 GRIN 变异个体（15/34）从美金刚治疗中获益显著较少，但不良事件罕见（3/15）。此外，变异距离美金刚结合位点越远，与临床获益越相关。
> 
> 研究意义：本回顾性观察性研究强调，在临床试验中应用美金刚或其他精准治疗方案前，准确分类 GRIN 变异的致病性及功能后果的重要性。此外，GoF 变异与美金刚结合位点之间的距离与积极的治疗反应相关，并可能部分解释治疗获益程度的差异。

### 第二部分 AI 大师评价

本研究旨在探索美金刚治疗 GRIN 功能增强型变异个体的疗效。通过回顾性分析 34 例病例并结合体外功能测定，研究发现 GoF 型变异个体较 LoF 型更有可能获得行为、发育及癫痫控制方面的改善。研究进一步揭示变异与药物结合位点的空间距离可能影响临床反应。该工作强调了精准表征 GRIN 变异对指导个体化治疗的重要性，其创新在于将功能基因组学与药物反应关联，但受限于样本量及回顾性设计。

---

## 5. 漏服药物是否会急性改变癫痫发作风险？一项前瞻性研究。

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41489031)
**期刊：** Annals of neurology
**PMID：** 41489031
**DOI：** 10.1002/ana.78134

### 第一部分 原文与翻译

**英文原标题：** Does Missing Medication Acutely Change Seizure Risk? A Prospective Study.

> **英文摘要：**
> OBJECTIVE: The objective of this study was to determine whether missing individual doses of anti-seizure medications (ASMs) elevate short-term seizure risk in people with drug-resistant epilepsy.
> 
> METHODS: In a prospective, community-based cohort, adults with drug-resistant epilepsy (≥ 3 seizures/month) or their caregivers recorded seizures and ASM intake with smartphone applications for 10 months each. Individual level analysis modeled the relationships between ASM adherence with seizure occurrence, as well as with a simplified seizure forecast via a 90-day moving average ("Napkin method"). Group-level analysis with a mixed-effects model was performed to examine the relationship between ASM adherence and simplified forecasts, while controlling for differences in individual seizure frequency via random effects.
> 
> RESULTS: Twenty-seven participants (median age = 29 years) contributed 7,853 person-days. Individual analysis showed that only a small (n = 2) number of participants had a weak relationship between ASM adherence with seizure occurrence. Group-level analysis showed that seizure occurrence was highly linked to the Napkin method, but not ASM adherence.
> 
> INTERPRETATION: Among individuals with frequent, drug-resistant epilepsy, occasional missed ASM doses did not measurably raise immediate seizure risk. Whereas sustained nonadherence remains a clinical concern, clinicians may reassure patients that infrequent brief lapses are unlikely to trigger seizures acutely, yet they should continue emphasizing overall adherence for long-term seizure control. ANN NEUROL 2026.

> **中文摘要：**
> 目的：本研究旨在确定在药物难治性癫痫患者中，漏服单次抗癫痫药（ASM）是否会增加短期发作风险。
> 
> 方法：在一项前瞻性、基于社区的队列研究中，患有药物难治性癫痫（≥3次发作/月）的成年人或其照护者，通过智能手机应用程序记录为期10个月的癫痫发作及ASM用药情况。个体水平分析使用模型评估ASM依从性与癫痫发作之间的关系，并结合90天移动平均（“Napkin方法”）生成的简化发作预测。群体水平分析采用混合效应模型，在控制个体发作频率差异的前提下，探讨ASM依从性与简化预测之间的关系。
> 
> 结果：共有27名参与者（中位年龄29岁）提供了7,853人天的数据。个体分析显示，仅有少数（n = 2）参与者表现出ASM依从性与发作发生间存在较弱的相关性。群体分析显示，癫痫发作的发生与Napkin方法预测结果高度相关，但与ASM依从性无显著关联。
> 
> 结论：在频繁发作的药物难治性癫痫患者中，偶尔漏服ASM似乎不会显著增加即时发作风险。尽管长期依从性不良仍为重要的临床问题，临床医生可在保证强调持续依从性的同时，安慰患者短暂、偶发的漏服通常不太可能立即引发癫痫发作。

### 第二部分 AI 大师评价

该研究通过智能手机数据收集和多层次统计分析，首次系统评估了药物难治性癫痫患者短期漏服抗癫痫药后的实际发作风险。结果显示，单次偶发漏服并不会显著增加急性发作风险，但整体依从性仍对长期控制至关重要。研究设计创新在于利用移动健康技术和实时数据监测，而局限性在于样本量较小及个体差异较大，需进一步在更大规模人群中验证。

---

速递结束，祝您工作愉快！